Alterations in homologous recombination repair genes in prostate

AMP Webinar: Molecular Testing for Alterations in DDR Pathway Genes in Ovarian and Prostate Cancer

Characterization, Detection, and Treatment Approaches for Homologous Recombination Deficiency in Cancer: Trends in Molecular Medicine

Role of the DNA damage response in prostate cancer formation, progression and treatment

Frontiers Genetic Testing and Its Clinical Application in Prostate Cancer Management: Consensus Statements from the Hong Kong Urological Association and Hong Kong Society of Uro-Oncology

Real-world genetic testing patterns in metastatic castration-resistant prostate cancer

Homologous recombination deficiency (HRD) and genomic alterations. (a)

Clinical implications of homologous recombination repair mutations in prostate cancer - Cresta Morgado - 2022 - The Prostate - Wiley Online Library

PDF) Genomic Analysis of Three Metastatic Prostate Cancer Patients with Exceptional Responses to Carboplatin Indicating Different Types of DNA Repair Deficiency

High prevalence of DNA damage repair gene defects and TP53 alterations in men with treatment-naïve metastatic prostate cancer –Results from a prospective pilot study using a 37 gene panel - ScienceDirect

Targeting the DNA Repair Enzyme Polymerase θ in Cancer Therapy: Trends in Cancer